Journey Medical (DERM) Tax Provisions (2020 - 2026)

Journey Medical's (DERM) quarterly Tax Provisions came in at -$18000.0 in Q4 2025, down 130.0% on a QoQ basis from $60000.0 in Q2 2025.

Journey Medical (DERM) Tax Provisions (2020 - 2026) Analysis & Trends

Journey Medical (DERM) has 5 years of Tax Provisions data on file, last reported at -$18000.0 in Q4 2025.

Quarterly Tax Provisions changed N/A year-over-year to -$18000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $168000.0 (changed N/A YoY) and the FY2025 annual result came in at $42000.0, down 31.15% from the prior year.
Tax Provisions declined to -$18000.0 in Q4 2025, from $60000.0 in the prior quarter.
In the past five years, Tax Provisions ranged from a high of $8.3 million in Q4 2021 to a low of -$3.4 million in Q2 2021.
A 4-year average of $163333.3 and a median of $36500.0 in 2022 frame the typical range for Tax Provisions.
Annual changes were most pronounced in 2021 — Tax Provisions plunged 14773.91% — and 2023, when it jumped 869.23%.
Tracing DERM's Tax Provisions over 4 years: stood at $8.3 million in 2021, then sank by 99.84% to $13000.0 in 2022, then jumped by 869.23% to $126000.0 in 2023, then slumped by 114.29% to -$18000.0 in 2025.
The last three Tax Provisions figures came in at -$18000.0 (Q4 2025), $60000.0 (Q2 2025), and $126000.0 (Q4 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Haleon	43.85 Bn	42.88 Bn	-	-
2	Teva Pharmaceutical Industries	43.02 Bn	39.37 Bn	2.15 Bn	121.00 Mn
3	Zoetis	31.47 Bn	29.79 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.59 Bn	22.79 Bn	5.10 Bn	-310.32 Mn
5	United Therapeutics	22.20 Bn	19.53 Bn	683.80 Mn	39.70 Mn
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn	54.80 Mn
7	Neurocrine Biosciences	15.45 Bn	15.06 Bn	935.80 Mn	17.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	2.00 Mn
9	Dr Reddys Laboratories	10.10 Bn	9.94 Bn	-	-
10	Journey Medical	206.75 Mn	181.11 Mn	12.37 Mn	15,000.00

Download Data